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Background: The composition of a diet can influence myocardial metabolism and development of left ventricular
hypertrophy (LVH). The impact of a high-fat diet in chronic left ventricular volume overload (VO) causing eccentric
LVH is unknown. This study examined the effects of chronic ingestion of a high-fat diet in rats with chronic VO
caused by severe aortic valve regurgitation (AR) on LVH, function and on myocardial energetics and survival.
Methods: Male Wistar rats were divided in four groups: Shams on control or high-fat (HF) diet (15 rats/group) and
AR rats fed with the same diets (ARC (n = 56) and ARHF (n = 32)). HF diet was started one week before AR induction
and the protocol was stopped 30 weeks later.
Results: As expected, AR caused significant LV dilation and hypertrophy and this was exacerbated in the ARHF
group. Moreover, survival in the ARHF group was significantly decreased compared the ARC group. Although the
sham animals on HF also developed significant obesity compared to those on control diet, this was not associated
with heart hypertrophy. The HF diet in AR rats partially countered the expected shift in myocardial energy substrate
preference usually observed in heart hypertrophy (from fatty acids towards glucose). Systolic function was
decreased in AR rats but HF diet had no impact on this parameter. The response to HF diet of different fatty acid
oxidation markers as well as the increase in glucose transporter-4 translocation to the plasma membrane compared
to ARC was blunted in AR animals compared to those on control diet.
Conclusions: HF diet for 30 weeks decreased survival of AR rats and worsened eccentric hypertrophy without
affecting systolic function. The expected adaptation of myocardial energetics to volume-overload left ventricle
hypertrophy in AR animals seemed to be impaired by the high-fat diet suggesting less metabolic flexibility.Background
Bad dietary habits have been linked to the obesity epi-
demic in industrialized countries. High fat (HF) diets
were initially incriminated for this epidemic but this
hypothesis is now being challenged. The direct cardiac
toxicity of dietary sugar overabundance has been docu-
mented in animal models [1-3] but the effects of HF
diets on the heart are still controversial [4]. This is prob-
ably due to the variability of the HF diets that have been
studied in rodent models of heart diseases. For example,* Correspondence: jacques.couet@med.ulaval.ca
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been shown to cause contractile dysfunction [5] in
Wistar rats while a high fat/low carbohydrate diet
seemed less toxic for the heart even if its content in sat-
urated fatty acids was high [6].
HF diets have mostly been shown to be either neutral
or somewhat beneficial in rodents with LV pressure
overload [7,8]. A neutral response to a HF diet on
cardiac remodeling was also observed in a rat model of
ischemic heart failure [9]. The impact of a HF diet on
dilated cardiomyopathy and eccentric LVH resulting
from chronic LV volume overload (VO) has never been
studied.Ltd. This is an Open Access article distributed under the terms of the Creative
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http://www.biomedcentral.com/1471-2261/14/123Chronic LV-VO causes severe dilatation and eccentric
hypertrophy. It is encountered mostly in patients suffer-
ing from heart valve regurgitation (mitral or aortic). Un-
treated regurgitation will result in severe LV dilatation
and hypertrophy as well as slowly progressive systolic
dysfunction and heart failure [10]. The obesity epidemics
and the western diets have reached several developing
countries worldwide [11]. It is thus important to deter-
mine if dietary habits can influence the evolution of LV
VO diseases. This study was therefore designed to assess
the impact of a chronic high saturated fat diet on the
development of eccentric LV hypertrophy, function and
survival in rats with severe and chronic LV VO from
aortic valve regurgitation (AR).
Methods
Animals
Adult male Wistar rats were purchased from Charles
River (Saint-Constant QC, Canada) and divided in 4
groups as follows: 1) Sham-operated animals on control
diet (SC; n = 15); 2) AR control diet (ARC; n = 56), 3)
Sham on High-Fat diet (Adjusted calories diet (60% calo-
ries from fat), Cat. No. TD.06414 Harlan Teklad Madi-
son WI), (SHF; n = 12) and AR on High-Fat diet (ARHF
n = 32). The animals were maintained either on the
control diet (Purina Rat Chow #5012) containing 13%
calories from fat, 27% from protein and 60% from carbo-
hydrate (39.5 g/kg from starch; 4.1kCal/g) or the high-
fat diet containing 60% calories from fat, 19% protein
and 21% carbohydrate (34.3 g/kg from fat; 5.4 kCal/g).
The fatty acid profile (% of total fat) was 37% saturatedFigure 1 Survival Kaplan-Meier curves of rats with severe
chronic aortic valve regurgitation. AR rats were fed control chow
Untreated (ARC: solid line) or the high fat diet (ARHF: dotted line)
for 7 months.(control diet: 19%), 47% monounsaturated (control diet:
20%) and 16% polyunsaturated (control diet: 61%). The
high-fat diet was started one week before surgery in both
SHF and ARHF groups and continued for 30 weeks until
sacrifice. A second protocol with similar groups of ani-
mals was also investigated but for a shorter period of
8 weeks (n = 10/gr.). The protocol was approved by the
Université Laval’s Animal Protection Committee and
followed the recommendations of the Canadian Council
on Laboratory Animal Care.
Aortic regurgitation
Severe AR was induced by retrograde puncture of the
aortic valve leaflets as previously described [12]. A
complete echocardiographic exam with a HD11XE echo-
graph (Philips Medical Imaging, Andover, MA) was per-
formed two weeks after AR induction and the day before
sacrifice 30 weeks later. At the end of the protocol,
hearts were quickly dissected and all cardiac chambers
were weighed. LV was snap-frozen in liquid nitrogen
and kept at −80°C for further analysis. Serum samples
were kept for evaluation of lipids, glucose, insulin and
adiponectin using commercial kits.
Analysis of mRNA accumulation by quantitative RT-PCR
The analysis of LV mRNA levels by quantitative RT-PCR
has been described in details elsewhere [13].
Enzyme activity determinations
Left ventricle samples were assayed for maximal (Vmax)
enzyme activities. Small pieces of LV (20-30 mg) were
homogenized in a glass-glass homogenizer with 9 or 39
volumes of ice-cold extracting medium pH7.4 (250 mM
sucrose, 10 mM Tris–HCl, 1 mM EGTA) depending on
the enzyme activity assayed. Enzymatic activities were
determined as previously described [14,15].
Immunoblotting
Crude LV homogenates were separated by SDS-PAGE.
Preparation of membrane, nuclear and cytosolic frac-
tions for the analysis of Glut4 and IRS1 translocation or
AMPK subcellular localization were performed using
protocols described in the following articles [16,17]. Im-
munoblotting was performed as described elsewhere
[18]. All primary antibodies were used at a 1:1000 dilu-
tion and were purchased from Cell Signaling Technology
(Beverly, MA) or from Santa Cruz Biotechnology (Santa
Cruz,CA).
Statistical analysis
Results are presented as mean ± SEM unless specified
otherwise. Normality of the data was assessed by the
Pearson test. Inter-group comparisons were done using
two-way ANOVA and using Bonferroni post-test if
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Data and statistical analysis were performed using Graph
Pad Prism version 6.01 for Windows, (San Diego CA).
Results
Clinical data and animal characteristics
All animals were alive at the end of the 8-week protocol
with the exception of two deaths in the ARHF group. In
the longer 30-week protocol all control animals were
alive at the end. Seventy percent of AR animals fed with
the control chow were alive after 7 months compared to
less than 50% in the one receiving the high-fat diet
(Figure 1). Animals fed a high-fat diet (HF) were signifi-
cantly heavier (Figure 2A). The retro-peritoneal fat
content was markedly increased in the HF groups and
even more so in AR animals (Figure 2B). Caloric intake
by the animals was also higher in the HF groups
(Table 1). Glucose levels were slightly lower in HF ani-
mals. Insulin levels remained unchanged with the diet
but were slightly more elevated in AR animals. LeptinFigure 2 Heart hypertrophy is worsened by feeding AR rats with high
fat deposit weight (B) was evaluated at 2 and 7 months. Heart weight (C)
mean ± SEM. Two-way ANOVA analyses. ***: p < 0.001 versus sham-operate
P value below 0.05, a Bonferroni post-test was conducted: §§§: p < 0.001 vslevels were strongly increased in HF groups. The disease
status (AR or not) had no impact on these parameters
except for adiponectin levels which were lower in ARC
animals compared to ARHF ones.
Heart weight was increased in rats with AR (Figure 2C).
AR animals on the HF diet had a significantly higher heart
weight than those on the control diet. Sham-operated
animals fed with the HF diet had a similar heart weight to
SC animals. When indexed for tibial length (Figure 2D),
this difference in heart weight between ARC and ARHF
animals was still significant. LV weights followed the same
variations as for total heart weight (Table 1). Ejection
fractions in the two AR groups were similarly decreased.
Relative wall thickness (an index of LV remodeling) was
similarly decreased in AR rats fed or not with the HF diet
(Table 1).
LV hypertrophy markers
As illustrated in Figure 3A, ANP and BNP gene expres-
sion were clearly increased in the LV of AR animals but-fat (HF) diet. Evolution of the body weight (A) and retroperitoneal
and indexed heart weight (D; for tibial length). Results are reported as
d animals. If interaction between AR and diet was found to have a
. control diet corresponding group.
Table 1 Biometric and echocardiographic parameters
Sham Ctrl Sham HF AR Ctrl AR HF
Tibia, mm 60.3 ± 0.64 61.4 ± 0.31 61.0 ± 0.43 61.0 ± 0.56
LV, mg 1163 ± 34.0 1225 ± 34.2 1823 ± 77.0a 2046 ± 69.9a, c
EDD, mm 8.4 ± 0.14 8.5 ± 0.17 11.4 ± 0.18a 11.6 ± 0.18a
ESD, mm 3.8 ± 0.22 3.8 ± 0.20 6.7 ± 0.17a 6.6 ± 0.22a
EF,% 78.6 ± 1.81 80.1 ± 1.52 64.8 ± 1.05a 67.9 ± 1.63a
RWT 0.30 ± 0.005 0.29 ± 0.005 0.23 ± 0.005a 0.21 ± 0.005a
kCal/day 126 ± 4.0 130 ± 4.0 126 ± 2.3 134 ± 4.1
TG, mmol/l 1.1 ± 0.12 1.1 ± 0.12 1.4 ± 0.14 1.0 ± 0.11
Chol., mmol/l 3.1 ± 0.46 2.9 ± 0.12 2.6 ± 0.13 3.1 ± 0.17
Gluc., mmol/l 17.4 ± 1.53 17.3 ± 1.72 15.9 ± 1.19 15.0 ± 1.05
Insulin, μg/l 1.4 ± 0.25 1.1 ± 0.19 1.6 ± 0.21a 2.4 ± 0.70a
Leptin, mg/l 1.1 ± 0.17 2.0 ± 0.22b 0.7 ± 0.13 2.1 ± 0.22b
Adiponectin, mg/l 10.4 ± 0.76 10.4 ± 0.69 7.7 ± 0.34 10.4 ± 0.76c
Echo measurements obtained under 1.5% isoflurane anesthesia. LV left
ventricle, EDD end-diastolic diameter, ESD end-systolic diameter, EF ejection
fraction and RWT relative wall thickness. Animal daily food intake (kCal/day)
and plasma levels of glucose, triglycerides, insulin, leptin and adiponectin
plasma levels were estimated in animals sacrificed at 60 days post-AR. a:
p < 0.001 versus sham groups, b: p < 0.01 vs. control diet groups and c: p < 0.01
vs. corresponding AR group by Bonferroni post-test. HF: high-fat diet.
A
B
Figure 3 Evaluation by real-time quantitative RT-PCR of the
LV mRNA levels of genes related to LV hypertrophy (A) and
extracellular matrix remodeling (B). **: p < 0.01 and ***: p < 0.001
between sham and AR groups. §: p < 0.05 vs. corresponding
group on control diet. Sham (sham-operated animals) group
mRNA levels were normalized to 1 and are represented as a
black line on the different graphs. ANP, atrial natriuretic peptide;
BNP, brain natriuretic peptide; αMHC, myosin heavy chain alpha;
βMHC, myosin heavy chain beta; α/β: ratio of the two MCH forms;
Col1: collagen I; Col III: collagen III; Col IV: collagen IV Fn: fibronectin.
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heavy chain subunits gene expression was also modu-
lated similarly in both AR groups.
AR mildly stimulated Erk1/2 phosphorylation but
did not affect the activation p38 or Jnk (Figure 4A).
The HF diet reversed the AR effect on pErk1/2
(Figure 4A-B). Stat3 phosphorylation was strongly in-
creased in AR rats but the high-fat diet did not influ-
ence this parameter. Phosphorylation of Akt, mTOR
and S6 kinase were significantly increased in the LV of
ARC animals whereas only a trend was observed for
4eBP1 (Figure 4C). The HF diet on the other hand
reversed this effect on mTOR and the S6 kinase
and reduced basal phosphorylation levels of 4eBP1
(Figure 4C-D). Myocardial interstitial and peri-vascular
fibrosis was significantly increased in AR rat but the HF
diet was not associated with additional fibrosis (Additional
file 1: Figures S1 and S2).
GSK3β and FoxO inactivation by the HF diet in eccentric LVH
Phosphorylation of GSK3β and of FoxO1 and 3a leads to
their inactivation by inhibiting the kinase activity of the
former and nuclear localization of FoxOs [19,20]. We
observed that AR was associated with higher levels of
FoxO 1 and 3a phosphorylation. On the other hand, the
HF diet doubled phosphorylation levels of GSK3β while
decreasing those of FoxO1 and 3a (Figure 5E-F).
Cardiac metabolism
We have previously showed that eccentric LVH caused
by severe AR was associated with a shift in energysubstrates preference from fatty acids to glucose [14,15,21].
Hydroxyacyl-Coenzyme A dehydrogenase (HADH) was re-
duced in AR animals (Figure 6A). The HADH enzymatic
activity was increased by the HF diet in sham and AR
animals, normalizing this parameter in the latter
group. The findings were similar for the malonyl-CoA
decarboxylase (MCD) enzymatic activity (Figure 6B).
We then measured mRNA levels of a set of genes re-
lated to FAO in the LV. As illustrated in Figure 6C, the
HF diet was associated with an almost overall increase
in gene expression of these genes in control animals
whereas AR rats on the control diet displayed de-
creased levels. The administration of the HF diet to the
AR animals failed to normalize the gene expression of
all but one of these genes (Fat/CD36).
Hexokinase (HK) activity is increased in the LV myocar-











Figure 4 The high fat diet impact on LV signaling in AR rats.
Phosphorylated protein content of various signaling molecules implicated
in cardiac growth and hypertrophy were evaluated by immunoblotting.
SC protein levels were normalized to 1 and are represented as a black
line on the different graphs (A and C). *: p < 0.05, **: p < 0.01 and ***: p <
0.001 between sham and AR groups. §: p < 0.05 vs. corresponding group
on control diet. ARC animals are represented by the white columns and
the ARHF the solid ones. Representative blots are also illustrated (B and D).
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fructokinase activity was increased to a similar extent in
HF diet fed animals (Figure 7B). The HF diet was also as-
sociated with higher mRNA levels of the pyruvate de-
hydrogenase α1 (PDHα1), pyruvate dehydrogenase kinase
4 (PDK4) as well as of glucose transporter 1 (Glut1)
(Figure 7C). We also evaluated insulin-sensitive glucose
transporter-4 (Glut4) translocation to the sarcomeric
membrane (Figure 7D and F). AR increased this transloca-
tion compared to sham animals fed or not with the HF
diet. The HF diet completely reversed this finding in AR
and reduced Glut4 translocation to sub-normal levels. We
also investigated if this finding could be explained by a
variation in the insulin receptor signaling pathway activa-
tion by measuring the content of IRS1 recruitment to the
plasma membrane (Figure 7E-F). As for Glut4, IRS1 was
more present at the membrane in AR rats fed with the
control chow. The HF diet decreased this parameter in
AR rats.
Citrate synthase activity was reduced in AR animals
but HF diet reversed this trend (Figure 8A). The com-
plex 1 activity remained mostly unchanged but was in-
creased in AR animals fed with the HF diet (Figure 8B).
Succinate dehydrogenase activity was decreased in SHF
and ARC animals but not in ARHF (Figure 8C). Total
CK activity was slightly decreased in AR animals (not
shown). Gene expression for the adenine nucleotide
translocator-1 (ANT1) was reduced in both AR groups
(Figure 8D). Uncoupling protein 3 (UCP3) mRNA levels
were strongly increased in sham animals fed the HF diet.
This was not case in AR animals where UCP3 expres-
sion remained unchanged.Discussion
Obesity has been known as an independent risk factor
for cardiovascular disease [22] but the contribution of
obesity-induced comorbidities such as dyslipidemia,
hypertension or type II diabetes has to be taken into ac-
count. In humans, however, “uncomplicated” isolated
obesity has been shown to be linked with cardiac anom-
alies too [23,24]. Dietary habits clearly play a major role
in the development of obesity and its associated
complications.
Divergent results have been reported in experimental
models of diet-induced obesity and heart disease depend-
ing on the composition of the abnormal diet. Some studies
have suggested that diet-induced obesity does not alter
cardiac function [6,25] while others reported various car-
diac systolic and/or diastolic function anomalies [26-29].
Feeding animals with LV pressure overload with a HF diet
had neutral effects in some studies [7,8,30] but adverse ef-
fects in another [31]. A HF diet suggested some benefits
































Figure 5 AMPK phosphorylation and cellular sub-localization, GSK3β and FoxO phosphorylation. Phosphorylated protein contents of LKB1
and AMPKα2 subunit remains unchanged in the LV myocardium of AR rats fed or not with a high fat diet. SC protein levels were normalized to 1
and are represented as a black line on the different graphs (A, C and E). ***: p < 0.001 between sham and AR groups. §§: p < 0.01 and §§§: p < 0.001
vs. corresponding group on control diet. Representative blots are also illustrated (B, D and F).
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http://www.biomedcentral.com/1471-2261/14/123In our model of LV volume overload from AR with se-
vere eccentric LVH, the HF diet was associated with in-
creased LVH and poorer survival. It could be argued
that the increase in heart weight in ARHF could be re-
lated only to the increased body mass. However a similar
increase in heart weight should have been observed in
the overweight sham animals fed the HF diet. Excessive
weight gain may have played a role but it clearly was not
the main factor to explain the differences. It is possible
that a synergy between hemodynamic overload, diet and
hypertrophy which are all pro-hypertrophic factors exist
but the mechanisms for the increased hypertrophy in
AR rats fed with the HF diet remain unclear. We ob-
served in the past that the Erk 1/2 and Stat3 pathways
are activated in AR [14,15,33]. We did not observe such
an activation for the Akt/mTOR pathway in the short
protocols (8 weeks) but we did in longer ones (current
and [34]). Here, the HF diet returned the activation
levels both Erk and mTOR pathways to normal suggest-
ing that they were not responsible for the increased LVH
observed in ARHF. Additional LVH may be caused bythe inhibition of anti-hypertrophic molecules such as
GSK3β and FoxOs. We observed increased phosphoryl-
ation of these molecules in AR rats fed with the HF diet,
likely leading to their inactivation. GSK3β phosphoryl-
ation impairs its inhibition in various pathways linked to
hypertrophy or cardiac growth including Wnt and NFAT
signaling [35]. FoxO favors transcription of atrogin-1, an
ubiquitin ligase that promotes calcineurin degradation
and can prevent NFAT activation.
Many myocardial metabolic enzymes were modulated
both by the state of severe LV-VO and by the diet. The
activity level of HADH was increased in SHF animals
but not in SC ones. The expression of the fatty acid
transporters (Fat/CD36 and CPTs) were all increased in
animals on the HF diet with the exception of Fat/CD36
in the ARHF group. HF diet seems to have a stimulating
effect on FAO in sham animals but this effect was some-
what blunted in AR animals. We also measured the ac-
tivity levels of two enzymes of the citric acid cycle.
Citrate synthase levels remained relatively stable among





























Figure 6 Impact of a high-fat diet on FAO in chronic eccentric LV hypertrophy. HADH (A; hydroxyacyl-Coenzyme A dehydrogenase) and
MCD (B; malonyl-CoA decarboxylase) enzymatic activities were measured as described in the Materials and Methods. In panel C, evaluation by
real-time quantitative RT-PCR of the LV mRNA levels of genes related to FAO. Sham group mRNA levels were normalized to 1 and are represented as a
black line on the graph. *: p < 0.05 and ***: p < 0.001 between sham and AR groups. §: p < 0.05, §§: p < 0.01 and §§§: p < 0.001 vs. corresponding sham
or AR group.
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in a pressure overload rat model [7]. In our model the
HF diet helped restore normal levels of SDH activity.
The discrepancies between the impacts of HF diet in
pressure versus volume overload models are interesting
and raise some questions. Our results suggest that FAO
capacity is not increased in AR animals fed a HF diet.
The main source of fat in our HF diet was lard and the
diet was started one week before AR induction. Unlike
mice in Raher et al. [31], our rats did not seem to de-
velop any clear form of metabolic syndrome or overt
diabetes despite an important increase in body mass.
Our results are nevertheless in line with some of the ob-
servations made in their mouse pressure-overload
model. We observed more LV hypertrophy in rats onthe HF diet. We also found an increase in circulating
leptin in our animals. Leptin has been shown to promote
the hypertrophy of cardiac myocytes [36]. A severe pro-
hypertrophic stimulus suddenly imposed to a heart with
preexisting elevated leptin levels could induce an exces-
sive hypertrophic response. Therefore, the response to
this pro-hypertrophic stress may have been amplified
from the very start since the HF diet had been started
before AR. The heart goes through a hyper-contractile
phase to compensate for the acute volume overload in
the first days following AR induction [12]. The heart has
to maintain its contractile capacity and to simultan-
eously activate the remodeling process. These two pro-
cesses both require additional energy and the HF diet
could have caused enough metabolic derangements to
Figure 7 The high fat diet in AR rats seems to impair the switch from fatty acid to glucose as preferred myocardium energy substrate.
HK (A; hexokinase) and PFK (B; phosphofructokinase) enzymatic activities were measured as described in the Materials and Methods. Evaluation
by real-time quantitative RT-PCR of the LV mRNA levels of other genes related to glucose oxidation is illustrated in panel C. D, Increased Glut4
translocation to the plasma membrane is reversed by the high fat diet in AR rats as evaluated by immunoblotting. E, Recruitment of IRS1 to the
membrane in the LVs of AR rats is partly reversed by the high fat diet. F, Representative blots are illustrated. *: p < 0.05 and ***: p < 0.001 between
sham and AR groups. §: p < 0.05, §§: p < 0.01 and §§§: p < 0.001 vs. corresponding sham or AR group.
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HF diet was started at the time of surgery. This may ex-
plain why the authors did not observe any increased LV
hypertrophy in their model despite similar metabolic as-
sessments at the end of their protocol [7,8].
The fatty acid composition of the HF diet may influ-
ence its effects on the heart. In our study, the content
of saturated and monounsaturated fatty acids was in
excess of 80% of total fat. A higher content in polyun-
saturated fatty acids may have led to different results.
It was shown that a diet rich in omega-3 polyunsatur-
ated fatty acid and complex carbohydrates could confer
a “lipo-protection” and decrease LV hypertrophy in
an pressure overload mouse model [37,38]. This obser-
vation suggests that the composition of a HF diet
specifically influence the hypertrophic response of the
overloaded heart. These alternate high-fat diets with a
“better” fat profile will need to be tested in upcoming
protocols.
In addition to perturbing myocardial FAO, we ob-
served that glycolysis seemed altered by the HF diet. AR
LVH is associated with a shift in energy preference to-
wards glucose [15]. We showed that Glut4 translocation
to the membrane is increased in AR animals suggesting
an increased glucose uptake capacity. The HF diet com-
pletely obliterated this increase thus probably impairingthe expected metabolic switch. This, in addition of prob-
ably less efficient FAO in the myocardium of AR rats fed
with the HF diet could lead to increased lipotoxicity and
poorer survival.
The overall oxidative capacity of the AR myocardium
did not seem to be negatively altered by the HF diet. It has
been reported that a HF diet in healthy rats was associated
with increased FAO and oxygen consumption without an
increase in function and thus with a decrease in cardiac ef-
ficiency. Uncoupling was also increased in the mitochon-
dria, maybe as a protective mechanism against reactive
oxygen species (ROS) production [39,40]. Our results sug-
gest a similar status in our SHF animals. In AR animals,
uncoupling seems less active as suggested by the return to
normal UCP3 expression. This could lessen the mitochon-
drial capacity to inhibit ROS production.
The exact reason why survival was decreased in the
AR-HF group cannot be determined with certainty. Sur-
vival in humans with AR is directly related to LV dilatation
and hypertrophy which is in line with our animal findings.
Larger, more hypertrophied hearts are obviously more fra-
gile and may be prone to pro-arrhythmia and sudden
death. We did not observe any clear morphological
changes in the hearts of sham-operated animals fed with
the HF diet even though they were clearly overweight












Figure 8 The high fat diet impact on myocardial mitochondria. HK (A; hexokinase), complex 1 (B) and SDH (C; succinate dehydrogenase)
enzymatic activities were measured as described in the Materials and Methods. Evaluation by real-time quantitative RT-PCR of the LV mRNA levels
of ANT1 (adenine nucleotide translocator-1) and UCP-3 (uncoupling protein-3) is illustrated in Panel D. **: p < 0.01 and ***: p < 0.001 between
sham and AR groups. §: p < 0.05 and §§§: p < 0.001 vs. corresponding sham or AR group.
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hypertrophy in healthy normal animals after 15 weeks.
The investigators noticed an increase in bogy weight,
circulatory insulin and leptin levels as well as an increase
in myocardial collagen deposition in their animals [27].
They also observed an increase in the papillary muscle
stiffness suggesting diastolic dysfunction. In a shorter
study (12 weeks) using Sprague–Dawley rats, Carroll and
collaborators did not report any cardiac abnormalities
[25]. Longer studies may be necessary to reveal the true ef-
fects of a HF diet in those animals.Conclusions
In conclusion, a HF diet rich in saturated fatty acids is
associated with increased eccentric hypertrophy and
poorer survival in a model of LV volume overload from
severe AR. This suggests that dietary habits and obesity
may influence the evolution of volume overload cardio-
myopathy and may also possibly have an impact on sur-
vival. This could be explained in part, by the activation
of pro-hypertrophic signals controlled by the GSK3β andFoxOs and an improper metabolic adaptation of the
myocardium. This hypothesis could be tested in humans
and the impact of dietary counseling and weight man-
agement in patients with VO should be emphasized.
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eccentric hypertrophy from chronic aortic regurgitation.
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